Navigation Links
Sir David Lane honored with Royal Gold Medal by Royal Society of Edinburgh
Date:9/16/2008

Sir David Lane, chairman of Singapore A*STAR's Biomedical Research Council, has received the Royal Gold Medal for his outstanding contribution to cancer research through his discovery of p53 tumour suppressor gene.

The Royal Gold Medal is one of the highest accolades from the Royal Society of Edinburgh and is given to recipients whose intellectual endeavour have made an impact on people's lives worldwide.

Dr. Lane termed the tumour suppressor, p53, which was discovered back in 1979[1] as the "Guardian of the Genome". It is the single most crucial defence the cell has against cancer, and it affects cell cycle processes from cancer to ageing. p53 is a crucial target in cancer therapy and research into it is essential in understanding the cell cycle.

Co-discoverers of p53 are Arnold Levine and William Old as well as Dr. Lane.

Congratulating Dr. Lane, A*STAR (Agency for Science, Technology and Research) Chairman Lim Chuan Poh said, "David is most deserving of the award, and I extend my deepest congratulations to him. His outstanding work on p53 and the impact they have on cancer research worldwide highlight the contributions of basic research to advancing human healthcare. David is an example of how a passionate and persevering scientist can make such a difference to the world through research and development."

Dr. Lane is also the founder and chief executive of A*STAR's Experimental Therapeutics Centre, which carries out developmental work and pre-clinical evaluation on potential new drugs discovered in A*STAR research institutes. His work on p53 in Singapore is still ongoing at A*STAR's Institute of Molecular and Cell Biology.

He is concurrently the Chief Scientist for Cancer Research UK, UK's largest cancer charity.


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1

Related biology news :

1. American Society for Microbiology honors David J. Lipman
2. Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU
3. Prof. David Kisailus studies engineering and invention on the half-shell
4. David H. Ledbetter, PhD, FACMG is the 2008-2009 Luminex/ACMGF Award recipient
5. Inaugural Kavli laureates honored in Oslo ceremony
6. Leader of Human Genome Project honored with the Inamori Ethics Prize
7. Sen. Byron Dorgan to be honored
8. Springer editor honored with top environmental prize
9. Yales Anastas honored for leadership in founding of green chemistry
10. NJIT Provost Priscilla P. Nelson honored at National Academy of Engineering
11. Jeremy Jackson honored by Harvard Museum of Natural History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/3/2017)... VEGAS , Jan. 3, 2017 Onitor, ... the introduction of Onitor Track, an innovative biometric data-driven ... men, showcasing this month at the 2017 Consumer Electronics ... In the U.S., the World Health ... more than two-thirds of adults who are overweight or ...
(Date:12/19/2016)... 19 de diciembre de 2016  Mosaic Biomedicals SL anunció hoy ... de MSC-1, un anticuerpo humanizado que se espera comenzar a utilizar ... múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el primer ... leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos tumores ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
(Date:1/19/2017)... Linda, Ca (PRWEB) , ... January 18, 2017 ... ... virtual events for tech innovators, engineers, and scientists from around the world, was ... American News. The awards program is based entirely on merit and decided upon ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
(Date:1/18/2017)... , January 18, 2017 According to a new market ... Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research ... to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, ... ... MarketsandMarkets Logo ...
Breaking Biology Technology: